{"public_id":"co_01294016a70c30daad876a2a9f3d2b8b","status":"active","merged_into_public_id":null,"resolved_public_id":"co_01294016a70c30daad876a2a9f3d2b8b","name":"obesity","description":"A condition whose progression to insulin resistance and type 2 diabetes is linked to fatty acid transporter involvement.","aliases":[],"types":["condition","disease"],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":3,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":3},"verdict_counts":{"approve":2,"reject":1},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":6504092,"title":"Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease.","citation_count":724,"url":"https://sah.borca.ai/papers/6504092"}],"claims":[{"public_id":"cl_e9c48cfc62f315c9f42d1784f0265fa6","text":"Studies in humans and animal models have implicated fatty acid transporters in the pathogenesis of diseases such as progression of obesity to insulin resistance and type 2 diabetes.","corpus_id":6504092,"url":"https://sah.borca.ai/claims/cl_e9c48cfc62f315c9f42d1784f0265fa6"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_01294016a70c30daad876a2a9f3d2b8b","url":"https://sah.borca.ai/concepts/co_01294016a70c30daad876a2a9f3d2b8b"}